Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.3.1 (
citrate synthase
)
4,488
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Obesity, which is caused by energy uptake being greater than energy expenditure, is widely prevalent today. Currently, only a limited number of efficient interventional strategies are available for the prevention of obesity. Previous studies have shown that
UCP4
transcription occurs at a considerable level in mouse skeletal muscle; however, the exact functions of
UCP4
remain unclear. In this study, we investigated the effect of
UCP4
on mitochondrial function and insulin sensitivity in mature L6 myocytes.
UCP4
overexpression in L6 myocytes induced increased mitochondrial carnitine palmitoyltransferase 1A (CPT1A) and decreased
citrate synthase
(CS) mRNA in the basal condition (i.e., in the absence of insulin).
UCP4
overexpression significantly improved insulin sensitivity, increased tyrosine phosphorylation of IRS-1 in the presence of insulin, and significantly reduced intracellular triglyceride (TG). Additionally, intracellular ATP content and mitochondrial membrane potential were downregulated. We also observed that intracellular ROS, mitochondrial morphology, and mitochondrial mtDNA copy number were maintained upon
UCP4
expression, with no change in mitochondrial fusion and fission. In summary, our findings provide evidence to show that
UCP4
overexpression reduced the insulin sensitivity and mitochondrial fatty acid oxidation of L6 myocytes. These findings support the notion that UCPs are ideal targets for treatment of insulin resistance.
...
PMID:UCP4 overexpression improves fatty acid oxidation and insulin sensitivity in L6 myocytes. 2160 79